| Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939) |
|---|
| 01/03/2002 | WO2002000606A1 Biphenyl compound |
| 01/03/2002 | WO2002000574A2 Catalysis using phosphine oxide and sulfoxide compounds |
| 01/03/2002 | WO2002000213A1 Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the composition |
| 01/03/2002 | WO2002000200A1 Novel process for preparing crystalline particles |
| 01/03/2002 | WO2001040184A3 Methods for the syntheses of alfentanil, sufentanil and remifentanil |
| 01/03/2002 | US20020002268 Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides |
| 01/03/2002 | US20020002213 Dental composition with improved light stability |
| 01/03/2002 | US20020002167 Calcium channel antagonists used to treat ischemic cerebrovascular disorders |
| 01/03/2002 | US20020002158 Potentiation of glutamate receptor function; treating central nervous system disorders |
| 01/03/2002 | US20020002152 Methionine aminopeptidase type 2 inhibitors; n'-((2S,3R)-3-amino-2-hydroxy-5-(isopropylsulfanyl)pentanoyl)-3-chloro benzoyl hydrazide |
| 01/03/2002 | DE10028204A1 Verfahren zur Auffindung von medizinisch wertvollen Wirkstoffen Method for identifying medically valuable active ingredients |
| 01/03/2002 | CA2412490A1 Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the composition |
| 01/02/2002 | EP1167342A1 Novel substituted nitrocatechols, their use in the treatment of some central and peripheral nervous system disorders and pharmaceutical compositions containing them |
| 01/02/2002 | EP1167341A1 Substituted nitrated catechols, their use in the treatment of some central and peripheral nervous system disorders and pharmaceutical compositions containing them |
| 01/02/2002 | EP1167329A2 Oxidation of carbon-boron bonds |
| 01/02/2002 | EP1165545A1 Novel compounds |
| 01/02/2002 | EP1165543A1 PROCESS FOR PREPARING S-(R*,S*)] -$g(b) - 1- 1-OXO-3- (4-PIPERIDINYL) PROPYL] -3-PIPERIDINYL] CARBONYL] AMINO] -3- PYRIDINEPROPANOIC ACID AND DERIVATIVES |
| 01/02/2002 | EP1165532A1 Antibacterial agents |
| 01/02/2002 | EP1165509A1 Method of producing 3,4-dihydroprolines and 3,4-dehydropiperidines |
| 01/02/2002 | EP1165508A1 Anticancer calcium channel blockers |
| 01/02/2002 | EP1165505A1 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
| 01/02/2002 | EP1165500A1 Amide derivatives as inhibitors of matrix metalloproteinases,tnf-alpha,and aggrecanase |
| 01/02/2002 | EP1165080A2 Use of substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds for treating hepatitis virus infections |
| 01/02/2002 | EP1164848A1 Compositions and methods for preventing and treating sexual dysfunctions |
| 01/02/2002 | CN1329595A New processes for producing beta-alanine derivative |
| 01/02/2002 | CN1329594A Ureidopiperidine derivatives as selective human NK3 receptor antagonists |
| 01/01/2002 | US6335460 Treating retroviral infections, including human immunodeficiency virus, and aids |
| 01/01/2002 | US6335444 Amino alcohol derivative and method for preparing the same |
| 01/01/2002 | US6335350 Acetamide and substituted acetamide-containing thiourea inhibitors of herpes viruses |
| 01/01/2002 | US6335348 Administering pipecolic acid derivative as cognition activator and to treat eye and nervous system disorders |
| 01/01/2002 | US6335334 Hypertensive agents, anticoagulants; cardiovascular and sexual disorders, angina pectoris, and atherosclerosis |
| 01/01/2002 | US6335329 Carboxylic acid substituted heterocycles, derivatives thereof and methods of use |
| 01/01/2002 | CA2056799C 1,4-dihydropyridine derivatives and methods of producing the same |
| 12/27/2001 | WO2001098273A1 Novel compounds |
| 12/27/2001 | WO2001098272A1 Novel compounds |
| 12/27/2001 | WO2001098271A1 4-substituted piperidine compound |
| 12/27/2001 | WO2001098270A2 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 12/27/2001 | WO2001098269A2 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 12/27/2001 | WO2001098268A2 Piperidine amides as modulators of chemokine receptor activity |
| 12/27/2001 | WO2001098266A2 N-and o-substituted 4-[2-(diphenylmethoxy)-ethyl]-1-[(phenyl)methyl]piperidine analogs and methods of treating cns disorders therewith |
| 12/27/2001 | WO2001098251A1 Novel substituted nitrocatechols, their use in the treatment of some central and peripheral nervous system disorders and pharmaceutical compositions containing them |
| 12/27/2001 | WO2001098250A1 Substituted nitrated catechols, their use in the treatment of some central and peripheral nervous system disorders and pharmaceutical compositions containing them |
| 12/27/2001 | WO2001097810A2 Use of therapeutic benzamide derivatives |
| 12/27/2001 | US20010056186 Process for preparing piperidines |
| 12/27/2001 | US20010056184 Pipecolinic acid derivatives, method of manufacturing the same and therapeutic agents containing these compounds |
| 12/27/2001 | US20010056123 Benzamidine derivatives |
| 12/27/2001 | US20010056107 Cyano and carboxy derivatives of substituted styrenes are inhibitors of tumor necrosis factor alpha , nuclear factor kappa B, and phosphodiesterase and can be used to treat cachexia, endotoxic shock, inflammatory conditions etc. |
| 12/27/2001 | US20010056103 Non-immunosuppressive, piperidino or pyrrolidino amide derivative has an affinity for an FKBP-type immunophilin, useful for treating Alzheimer's Disease, Huntington's Disease, Parkinson's Disease, amyotrophic lateral sclerosis |
| 12/27/2001 | US20010056102 Crystals of piperidine derivatives, intermediates for production of the same, and process for producing the same |
| 12/27/2001 | US20010056090 3-substituted piperidines comprising urea functionality, and methods of use thereof |
| 12/27/2001 | CA2413421A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 12/27/2001 | CA2413418A1 Piperidine amides as modulators of chemokine receptor activity |
| 12/27/2001 | CA2413274A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 12/27/2001 | CA2411255A1 Novel compounds |
| 12/26/2001 | CN1328457A Use of N-substituted-1,5-dideoxy -1,5-imino-D-glucitol compounds for treating hepatitis virus |
| 12/26/2001 | CN1328451A Drugs for improving vesical excretory strength |
| 12/26/2001 | CA2351256A1 Oxidation of carbon-boron bonds |
| 12/25/2001 | US6333342 Calcium channel blockers |
| 12/25/2001 | US6333340 Sulfonamides with oxo, ester or amide groups for vision defects and cognition activators |
| 12/25/2001 | US6333339 3-Benzylpiperidine |
| 12/25/2001 | US6333338 Anticoagulants, cardiovascular disorders |
| 12/21/2001 | CA2351129A1 Novel substituted nitrocatechols, their use in the treatment of some central and peripheral nervous system disorders and pharmaceutical compositions containing them |
| 12/21/2001 | CA2351125A1 Substituted nitrated catechols, their use in the treatment of some central and peripheral nervous system disorders and pharmaceutical compositions containing them |
| 12/20/2001 | WO2001096323A1 Serine protease inhibitors |
| 12/20/2001 | WO2001096306A1 Enantiomer separation of piperidone derivatives with simultaneous in situ racemization of the unwanted enantiomer |
| 12/20/2001 | WO2001096305A1 Serine protease inhibitors |
| 12/20/2001 | WO2001096304A1 Serine protease inhibitors |
| 12/20/2001 | WO2001096303A1 Serine protease inhibitors |
| 12/20/2001 | WO2001096302A1 Piperidines for use as orexin receptor antagonists |
| 12/20/2001 | WO2001096301A1 Processes for producing racemic piperidine derivative and for producing optically active piperidine derivative |
| 12/20/2001 | WO2001096296A1 Serine protease inhibitors |
| 12/20/2001 | WO2001095880A1 Novel pharmaceutical formulation suitable for nebulisation |
| 12/20/2001 | WO2001095856A2 Urea derivative useful as an anti-cancer agent and process for preparing same |
| 12/20/2001 | WO2001087838A8 Cyclohexane derivatives and their use as therapeutic agents |
| 12/20/2001 | WO2001051456A3 Antibacterial agents |
| 12/20/2001 | WO2000072834A9 Agent for expression of long-term potentiation of synaptic transmission comprising compound having brain somatostatin activation property |
| 12/20/2001 | US20010053862 Process for preparing arylpiperidine carbinol intermediates and derivatives |
| 12/20/2001 | DE10029851A1 Optical resolution of 2-substituted 4-piperidone derivatives, for use as pharmaceutical intermediates, by simultaneous formation of salt with optically active acid and racemization |
| 12/20/2001 | CA2411805A1 Serine protease inhibitors |
| 12/20/2001 | CA2411798A1 Serine protease inhibitors |
| 12/19/2001 | EP1164128A1 4-Cyanophenyliminoheterocycles |
| 12/19/2001 | EP1163239A1 Modified amino-acid amides as cgrp antagonists |
| 12/19/2001 | EP1163221A1 Sulfonamide derivatives as 5ht7 receptor antagonists |
| 12/19/2001 | EP1163213A1 Hydroxamic and carboxylic acid derivatives |
| 12/19/2001 | EP1094816A4 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| 12/19/2001 | CN1327444A Alpha 1 beta-adrenergic receptor antagonists |
| 12/19/2001 | CN1327443A Substituted anilides |
| 12/19/2001 | CN1327383A Pharmaceutical for treatment of neurological and neuropsychiatric disorders |
| 12/19/2001 | CN1076345C 2,3-diaminopropionic acid derivatives |
| 12/18/2001 | US6331631 Reacting 4-piperidinocarboxamide and 1-bromobutane, reduction with lithium aluminum hydride using toluene as solvent |
| 12/18/2001 | US6331563 N-Hydroxy-2-(Alkyl, Aryl, or Heteroaryl, Sulfanyl, Sulfinyl or Sulfonyl)-3-Substituted Alkyl, Aryl or Heteroarylamides as Matrix Metalloproteinase inhibitors |
| 12/18/2001 | US6331545 Heterocycyclic piperidines as modulators of chemokine receptor activity |
| 12/18/2001 | US6331542 Protease inhibitors |
| 12/18/2001 | US6331541 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 12/18/2001 | US6331537 Treating neurological disorders in animals |
| 12/18/2001 | US6331507 Substituted aromatic thiocarboxylic acid amides and their use as herbicides |
| 12/18/2001 | CA2117892C 4-diphenylmethyl piperidine derivatives and process for their preparation |
| 12/13/2001 | WO2001094612A2 Method for identifying medically valuable active substances |
| 12/13/2001 | WO2001094313A2 Crystal modification of fexofenadine |
| 12/13/2001 | WO2001094304A1 Process for the production of sulfonic esters |